The Trump administration issued two final rules Friday aimed at lowering prescription drug costs, seeking to advance President Trump’s “America First Healthcare Plan” and picking a fight with drugmakers two months before the end of his term.
The regulatory effort is notable in that it brings the Republican Party into open conflict with the pharmaceutical industry and is one of the few Trump initiatives that could be solidified under President-election Joe Biden.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.